Main Article Content
Background: Obviously, antibacterial agents are primarily directed against bacteria. However, because microorganisms can initiate an exaggerated inflammatory reaction, and as pathogens which persist in cryptic reservoirs (cells or granuloma tissue) can be the underlying cause of chronic inflammation, the hypothesis that antibacterials can down regulate inflammation. Methodology: Healthy adult mice weighing 20 - 30 g and aged 6-8 weeks, each group 6 mice were included. 1% carrageenan administered to produce inflammation. Grouping: Group 1: Normal saline 0.2 ml. i.p., Group 2: Diclofenac sodium 25mg/kg, Group 3 Ciprofloxacin 50 mg/kg, Group 4: Azithromycin 20mg/kg. Drugs were administered Intra Peritoneal. After 30 min of test drugs administration each group of mice were received subplantar administration of 0.05ml of saline (Control) or 0.05ml carrageenan (1%) for test groups 2 to 4. Paw volumes were measured by dipping in to the mercury plethysmograph at 30, 60, 120 and 180 minutes and results were tabulated. Results: Diclofenac, ciproflaoxin, Azithromycin inhibited paw edema in % at 30min 42.85, 28.55, 14.28, at 60min 75, 50, 25, at 120min 71.42, 42.85, 14.28, and at 180 min 50, 50, 25 respectively. Conclusion: Ciprofloxacin (50mg/kg) has exhibited consistent anti-inflammatory, but the anti-inflammatory activity of is less than that of Diclofenac sodium and Azithromycin also has exhibited anti-inflammatory activity, though much less when compared to Diclofenac sodium and Ciprofloxacin.
Key words: Anti inflammatory effect; Azithromycin; Ciprofloxacin; Diclofenac Sodium; Paw edema; Mice.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.